First Time Loading...

Ayala Pharmaceuticals Inc
NASDAQ:AYLA

Watchlist Manager
Ayala Pharmaceuticals Inc Logo
Ayala Pharmaceuticals Inc
NASDAQ:AYLA
Watchlist
Price: 0.5036 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

AYLA Price Targets Summary
Ayala Pharmaceuticals Inc

There are no price targets for AYLA.
AYLA Lowest Forecast
Wall Street Target
Not Available
AYLA Average Forecast
Wall Street Target
Not Available
AYLA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ayala Pharmaceuticals Inc Competitors:
Price Targets
FYB
Formycon AG
129% Upside
BCYC
Bicycle Therapeutics PLC
79% Upside
BIIB
Biogen Inc
34% Upside
A
AELIS
Aelis Farma SA
62% Upside
FYB
Formycon AG
129% Upside
BCYC
Bicycle Therapeutics PLC
79% Upside
BIIB
Biogen Inc
34% Upside
A
AELIS
Aelis Farma SA
62% Upside
GILD
Gilead Sciences Inc
30% Upside
MRNA
Moderna Inc
8% Upside
ARQT
Arcutis Biotherapeutics Inc
130% Upside
MRKR
Marker Therapeutics Inc
202% Upside

Revenue
Forecast

Revenue Estimate
Ayala Pharmaceuticals Inc

For the last 2 years the compound annual growth rate for Ayala Pharmaceuticals Inc's revenue is 23%. The projected CAGR for the next 2 years is -18%.

23%
Past Growth
-18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ayala Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ayala Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AYLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
AYLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AYLA stock valuation using valuation multiples.
Wall Street Estimates
AYLA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AYLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AYLA's stock price target?
Not Available

AYLA doesn't have any price targets made by Wall Street professionals.

What is Ayala Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-18%

For the last 2 years the compound annual growth rate for Ayala Pharmaceuticals Inc's revenue is 23%. The projected CAGR for the next 2 years is -18%.

ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.